Brand New Two-Track Agenda
The peptide field is vast, which is why we have meticulously researched with subject matter experts to identify the key challenges facing the community across drug discovery and formulation… the problems are different, but together we can tackle them.
By splitting into two tracks, our speakers have tailored their presentations to dive into specific challenges for those stages of development. By sending different members of the team across the drug pipeline, you can be sure you’ve left no stone unturned.
Drug Discovery
Overcome the challenges of crystal structure characterization, novel targets identification and leveraging computational methods to better understand and unlock peptide design, structure and functionality sharing insights from:
Formulation & CMC
Tackle oral bioavailability and route of administration challenges from enhanced permeation, cellular targeting and clinical safety with insights from:
4 Deep-Dive Workshops
Hear the latest advancements in peptide innovation across in-depth workshops solving emerging peptide challenges, from leveraging AI for peptide design, harnessing new tools from mRNA and phage display for peptide screening, leveraging peptides for drug conjugation and delivery strategies and optimizing the peptide analytical toolbox for effective translatability across model systems.
Business Development & Investment Panel
With the industry capitalizing from GLP-1 progress, to the potential of peptide across new disease indications, hear from leading biotech and investors as they empower you on forging alliances and seeking funding towards advancing peptide innovation and speed to clinic.
Testimonials
This meeting presents an opportunity to get the thought leaders in the world of peptide therapeutics together to share the contributions they are making to our industry. I believe that others will benefit from hearing our story and how we advanced multiple peptides into the clinic over the past 5 years; and we will benefit from learning similar info from our peers.
Barry Kappel, Sapience Therapeutics
As we continue to unlock the potential of peptide therapeutics as a validated modality, it is invaluable to connect with the leading experts in the field to share our learnings and ensure our collective success in delivering these transformative therapies into the clinic and toward meaningful impact for patients.
Shelley Allen, Abbvie
I see the Summit as a force multiplier. Peptide therapeutics sit at a pivotal point—between small molecules and biologics. Participating enables us to accelerate translation by aligning on design rules, delivery strategies, and CMC best practices; stress-test our assumptions with peers and regulators; and forge the right partnerships across academia, biotech, and large pharma.
Maria Fawaz, Merck & Co
The Summit will be an excellent opportunity to hear from thought leaders about advances in peptide-based therapeutics, the increasing importance of this modality, and where the field is heading in the next few years.
David Earp, Circle Pharma
Download the Full Event Guide
- Learn from 40+ Expert Speakers
- NEW Two-Track Agenda covering Drug Discovery and Formulation & CMC
- NEW Business Development & Investment Panel
- 4 Deep-Dive Workshops to choose from
- 25+ Data-Driven Case Studies to hear
Attending Companies Include
Explore the Agenda
Hear the latest industry breakthroughs and gain exclusive insights during our packed agenda, interactive roundtables, and panel discussions.
Partner With Us
Position yourself alongside other leading solution providers to ensure your brand is at the heart of biopharma deals.
Join Biopharma Experts
Be part of the hottest conversations with like-minded attendees spanning all stages of drug development and make critical connections during our dedicated networking sessions.